34 related articles for article (PubMed ID: 38519352)
1. University Cooperation Platform (UCP) between Christian-Albrechts-University Kiel (Germany) and Chiang Mai University (Thailand): implementation of image-guided gynecological brachytherapy.
Galalae R; Tharavichitkul E; Wanwilairat S; Chitapanarux I; Kimmig B; Dunst J; Lorvidhaya V
J Contemp Brachytherapy; 2015 Feb; 7(1):86-92. PubMed ID: 25829941
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial evaluating a novel hydrogel packing system compared to standard packing during image-guided high-dose rate brachytherapy boost for cervical cancer.
Romano KD; Petroni G; Ward K; Zheng W; Mistro M; Libby B; McLaughlin C; Showalter TN; Janowski EM
Brachytherapy; 2024; 23(3):248-256. PubMed ID: 38519352
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
Dincer N; Ugurluer G; Mustafayev TZ; Serkizyan A; Aydin G; Güngör G; Yapici B; Atalar B; Özyar E
Brachytherapy; 2024; 23(1):18-24. PubMed ID: 38000958
[TBL] [Abstract][Full Text] [Related]
5. The dosimetric impact of vaginal balloon-packing on intracavitary high-dose-rate brachytherapy for gynecological cancer.
Rockey WM; Bhatia SK; Jacobson GM; Kim Y
J Contemp Brachytherapy; 2013 Mar; 5(1):17-22. PubMed ID: 23634151
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of speculum-based vaginal packing for high-dose-rate intracavitary tandem and ovoid brachytherapy in cervical cancer.
Sud S; Roth T; Jones E
J Contemp Brachytherapy; 2018 Feb; 10(1):32-39. PubMed ID: 29619054
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vaginal gauze packing technique with or without balloon in high-dose-rate brachytherapy of uterine cervical cancer: A crossover randomized controlled trial.
Dhanapalan R; Pandjatcharam J; Saravanan K; Patil NH
J Contemp Brachytherapy; 2022 Dec; 14(6):551-559. PubMed ID: 36819474
[TBL] [Abstract][Full Text] [Related]
8. A comparison of dosimetric parameters in high-dose-rate intracavitary brachytherapy using tandem and ring applicators: is the combination of a rectal retractor and radio-opaque vaginal packing better than rectal retractor alone for rectum sparing in cervical cancer?
Vats S; Thakur S; Sharma M; Gupta M; Chandrakant L; Negi M; Verma S; Negi A; Kumar V; Sharma P; Negi RM
Ecancermedicalscience; 2022; 16():1439. PubMed ID: 36200012
[TBL] [Abstract][Full Text] [Related]
9. Geographic access to brachytherapy services in the United States.
Bates JE; Thaker NG; Parekh A; Royce TJ
Brachytherapy; 2022; 21(1):29-32. PubMed ID: 34148829
[TBL] [Abstract][Full Text] [Related]
10. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
[TBL] [Abstract][Full Text] [Related]
11. Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
Hung P; Deng S; Zahnd WE; Adams SA; Olatosi B; Crouch EL; Eberth JM
Cancer; 2020 Mar; 126(5):1068-1076. PubMed ID: 31702829
[TBL] [Abstract][Full Text] [Related]
12. Development and preclinical testing of a novel biodegradable hydrogel vaginal packing technology for gynecologic high-dose-rate brachytherapy.
Peach MS; Moore J; Giles W; Trainor J; Long T; Moon N; Hylton JE; Showalter TN; Libby B
J Contemp Brachytherapy; 2018 Aug; 10(4):306-314. PubMed ID: 30237814
[TBL] [Abstract][Full Text] [Related]
13. High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events.
Romano KD; Hill C; Trifiletti DM; Peach MS; Horton BJ; Shah N; Campbell D; Libby B; Showalter TN
Radiat Oncol; 2018 Jul; 13(1):129. PubMed ID: 30012164
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
